Biogen (BIIB) EV to CFO (2009 - 2026)
Biogen's (BIIB) EV to CFO stood at 10.64 in Q2 2026, up 43.9% from 7.40 a year earlier and up 21.0% from the prior quarter.
Powered by 
Analysis
Biogen (BIIB) EV to CFO (2009 - 2026) Analysis & Trends
On a TTM basis, Biogen's EV to CFO came in at 6.45 as of Jun 30, 2026, up 52.1% year-over-year; for FY2025, it came in at 9.99, up 44.2% from FY2024.
- Across earlier years, EV to CFO came in at 6.93 in FY2024 (-70.6%), 23.56 in FY2023 (-6.8%), 25.26 in FY2022 (+191.7%) and 8.66 in FY2021 (+5.6%).
- The Q2 2026 figure is the highest quarterly EV to CFO since Q3 2024.
- On a year-over-year basis, EV to CFO has increased for three consecutive quarters, with an average decline of 21.5% over the last eight quarters.
- Peak year-over-year performance for EV to CFO in the last five years was growth of 191.7% in Q4 2022, against a decline of 70.6% in Q4 2024 at the low end.
- Per Business Quant, the preceding three quarters came in at 8.79 (Q1 2026), 9.99 (Q4 2025) and 6.76 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | Biogen | 37.52 Bn | 24.18 Bn | 1.96 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 10.64 |
| Mar 31, 2026 | 8.79 |
| Dec 31, 2025 | 9.99 |
| Sep 30, 2025 | 6.76 |
| Jun 30, 2025 | 7.40 |
| Mar 31, 2025 | 6.76 |
| Dec 31, 2024 | 6.93 |
| Sep 30, 2024 | 12.48 |
| Jun 30, 2024 | 17.86 |
| Mar 31, 2024 | 18.43 |
| Dec 31, 2023 | 23.56 |
| Sep 30, 2023 | 25.70 |
| Jun 30, 2023 | 24.62 |
| Mar 31, 2023 | 20.97 |
| Dec 31, 2022 | 25.26 |
| Sep 30, 2022 | 13.98 |
| Jun 30, 2022 | 9.75 |
| Mar 31, 2022 | 8.93 |
| Dec 31, 2021 | 8.66 |
| Sep 30, 2021 | 16.05 |
API Access
Biogen EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=BIIB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "BIIB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=BIIB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();